Gallery Agency: Page & Page
- 1
- 2
Latest content
- Lilly’s Ebglyss approved by FDA as maintenance dose for atopic dermatitis
- The next frontier in clinical trials: navigating multi-disease research with GLP-1s
- GSK to acquire biopharma Nuvalent for $10.6bn
- CSL’s Privigen approved as measles treatment by European Commission
- Roche and Nurix Therapeutics to partner in $2.3bn deal
Latest intelligence
- The next frontier in clinical trials: navigating multi-disease research with GLP-1s
- Headline trade and market deals are opening doors to greater patient access
- Men’s health: the gap between awareness and action is where men’s lives are lost
- The digital age and the advance of AI – pushing communications to new heights
- GenAI: embracing the transformation – with caution




